DatSCAN In Differential Diagnostics of Lewy Body Disease
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F16%3A33160800" target="_blank" >RIV/61989592:15110/16:33160800 - isvavai.cz</a>
Výsledek na webu
<a href="http://eds.a.ebscohost.com/eds/pdfviewer/pdfviewer?sid=ae5a4c1e-2ad7-49b3-8a44-8c98feca532c%40sessionmgr4006&vid=1&hid=4203" target="_blank" >http://eds.a.ebscohost.com/eds/pdfviewer/pdfviewer?sid=ae5a4c1e-2ad7-49b3-8a44-8c98feca532c%40sessionmgr4006&vid=1&hid=4203</a>
DOI - Digital Object Identifier
—
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
DatSCAN In Differential Diagnostics of Lewy Body Disease
Popis výsledku v původním jazyce
Differential diagnosis between Lewy body disease and Alzheimer's disease might be difficult because of similarities of clinical symptoms in both neurodegenerative diseases. DatSCAN is a modern functional neuroimmaging method which differentiates between this similar diseases and helps in correct treatment strategy. We report our positive experience with DatSCAN in differentiating Lewy body disease from Alzheimer's disease. This is a case report of a woman with Lewy body disease, initially diagnosed as Alzheimer's disease. DatSCAN neuroimmaging method was used in differential diagnosis of dementia. Memory impairment, impaired activities of daily living, sleep and behavioral disturbances were present in our case. Donepezil was well tolerated, but haloperidol administration was followed by development of severe dystonia. DatSCAN showed deficient dopaminergic presynaptic transport in substantia nigra and striatum. This finding is typical for Lewy body disease not for Alzheimer's disease. DatSCAN neuroimmaging is a suitable method for differentiating Lewy body disease from Alzheimer's disease. Deficient dopaminergic presynaptic transport in substantia nigra and striatum is typical for Lewy body disease.
Název v anglickém jazyce
DatSCAN In Differential Diagnostics of Lewy Body Disease
Popis výsledku anglicky
Differential diagnosis between Lewy body disease and Alzheimer's disease might be difficult because of similarities of clinical symptoms in both neurodegenerative diseases. DatSCAN is a modern functional neuroimmaging method which differentiates between this similar diseases and helps in correct treatment strategy. We report our positive experience with DatSCAN in differentiating Lewy body disease from Alzheimer's disease. This is a case report of a woman with Lewy body disease, initially diagnosed as Alzheimer's disease. DatSCAN neuroimmaging method was used in differential diagnosis of dementia. Memory impairment, impaired activities of daily living, sleep and behavioral disturbances were present in our case. Donepezil was well tolerated, but haloperidol administration was followed by development of severe dystonia. DatSCAN showed deficient dopaminergic presynaptic transport in substantia nigra and striatum. This finding is typical for Lewy body disease not for Alzheimer's disease. DatSCAN neuroimmaging is a suitable method for differentiating Lewy body disease from Alzheimer's disease. Deficient dopaminergic presynaptic transport in substantia nigra and striatum is typical for Lewy body disease.
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FQ - Veřejné zdravotnictví, sociální lékařství
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2016
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Archives of Iranian Medicine
ISSN
1029-2977
e-ISSN
—
Svazek periodika
19
Číslo periodika v rámci svazku
6
Stát vydavatele periodika
IR - Íránská islámská republika
Počet stran výsledku
4
Strana od-do
449-452
Kód UT WoS článku
000378109300012
EID výsledku v databázi Scopus
—